210 related articles for article (PubMed ID: 35416080)
21. Head and Neck Cancer-Related Pain.
Khawaja SN; Scrivani SJ
Dent Clin North Am; 2023 Jan; 67(1):129-140. PubMed ID: 36404073
[TBL] [Abstract][Full Text] [Related]
22. Increased Pain Reporting by Head and Neck Cancer Patients at Radiation Oncology Consultation: A Quality-of-Life Analysis.
Havard M; Esslinger H; Mierzwa M; Kharofa J; Takiar V
Laryngoscope; 2021 Feb; 131(2):326-332. PubMed ID: 32609888
[TBL] [Abstract][Full Text] [Related]
23. Microphysiological head and neck cancer model identifies novel role of lymphatically secreted monocyte migration inhibitory factor in cancer cell migration and metabolism.
Yada RC; Desa DE; Gillette AA; Bartels E; Harari PM; Skala MC; Beebe DJ; Kerr SC
Biomaterials; 2023 Jul; 298():122136. PubMed ID: 37178589
[TBL] [Abstract][Full Text] [Related]
24. Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis.
Starska-Kowarska K
Nutrients; 2023 May; 15(11):. PubMed ID: 37299554
[TBL] [Abstract][Full Text] [Related]
25. Oral squamous cell carcinoma-derived EVs promote tumor progression by regulating inflammatory cytokines and the IL-17A-induced signaling pathway.
Li R; Zhou Y; Zhang M; Xie R; Duan N; Liu H; Qin Y; Ma J; Li Z; Ye P; Wang W; Wang X
Int Immunopharmacol; 2023 May; 118():110094. PubMed ID: 37030119
[TBL] [Abstract][Full Text] [Related]
26. High mobility group box 1 induces bone pain associated with bone invasion in a mouse model of advanced head and neck cancer.
Nakamura T; Okui T; Hasegawa K; Ryumon S; Ibaragi S; Ono K; Kunisada Y; Obata K; Masui M; Shimo T; Sasaki A
Oncol Rep; 2020 Dec; 44(6):2547-2558. PubMed ID: 33125145
[TBL] [Abstract][Full Text] [Related]
27. Role of the immune system in neuropathic pain.
Malcangio M
Scand J Pain; 2019 Dec; 20(1):33-37. PubMed ID: 31730538
[TBL] [Abstract][Full Text] [Related]
28. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
[TBL] [Abstract][Full Text] [Related]
29. Chronic Nutrition Impact Symptoms Are Associated with Decreased Functional Status, Quality of Life, and Diet Quality in a Pilot Study of Long-Term Post-Radiation Head and Neck Cancer Survivors.
Crowder SL; Li Z; Sarma KP; Arthur AE
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445046
[TBL] [Abstract][Full Text] [Related]
30. Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression.
Wang X; Qin X; Yan M; Shi J; Xu Q; Li Z; Yang W; Zhang J; Chen W
J Exp Clin Cancer Res; 2019 Apr; 38(1):151. PubMed ID: 30961650
[TBL] [Abstract][Full Text] [Related]
31. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
Roh JL; Park JY; Kim EH; Jang HJ
Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
[TBL] [Abstract][Full Text] [Related]
32. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer.
Chen CH; Chang AY; Li SH; Tsai HT; Shiu LY; Su LJ; Wang WL; Chiu TJ; Luo SD; Huang TL; Chien CY
Mol Cancer; 2015 Apr; 14():83. PubMed ID: 25889801
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of nuclear receptor REV-ERBs suppresses production of pronociceptive molecules in cultured spinal astrocytes and ameliorates mechanical hypersensitivity of inflammatory and neuropathic pain of mice.
Morioka N; Kodama K; Tomori M; Yoshikawa K; Saeki M; Nakamura Y; Zhang FF; Hisaoka-Nakashima K; Nakata Y
Brain Behav Immun; 2019 May; 78():116-130. PubMed ID: 30682503
[TBL] [Abstract][Full Text] [Related]
34. Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway.
Qin X; Yan M; Wang X; Xu Q; Wang X; Zhu X; Shi J; Li Z; Zhang J; Chen W
Theranostics; 2018; 8(4):921-940. PubMed ID: 29463991
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation.
Yu CC; Chen YW; Chiou GY; Tsai LL; Huang PI; Chang CY; Tseng LM; Chiou SH; Yen SH; Chou MY; Chu PY; Lo WL
Oral Oncol; 2011 Mar; 47(3):202-10. PubMed ID: 21292542
[TBL] [Abstract][Full Text] [Related]
36. A PI3K/AKT Scaffolding Protein, IQ Motif-Containing GTPase Associating Protein 1 (IQGAP1), Promotes Head and Neck Carcinogenesis.
Wei T; Choi S; Buehler D; Anderson RA; Lambert PF
Clin Cancer Res; 2020 Jan; 26(1):301-311. PubMed ID: 31597661
[TBL] [Abstract][Full Text] [Related]
37. Transcutaneous Electrical Nerve Stimulation Reduces Resting Pain in Head and Neck Cancer Patients: A Randomized and Placebo-Controlled Double-Blind Pilot Study.
Lee JE; Anderson CM; Perkhounkova Y; Sleeuwenhoek BM; Louison RR
Cancer Nurs; 2019; 42(3):218-228. PubMed ID: 29649082
[TBL] [Abstract][Full Text] [Related]
38. Neuropeptide Substance P Enhances Inflammation-Mediated Tumor Signaling Pathways and Migration and Proliferation of Head and Neck Cancers.
Singh S; Kumaravel S; Dhole S; Roy S; Pavan V; Chakraborty S
Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):93-102. PubMed ID: 33994734
[TBL] [Abstract][Full Text] [Related]
39. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
40. [Pathophysiology of low back pain and the transition to the chronic state - experimental data and new concepts].
Mense S
Schmerz; 2001 Dec; 15(6):413-7. PubMed ID: 11793144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
